Semiglutide is an FDA-approved drug prescribed to obese adults or who are overweight for chronic weight management. It’s an injectable weight loss solution that mimics GLP-1, which is the body’s naturally occurring hormone. Semaglutide work by stimulating your pancreas to increase insulin and inhibiting glucagon secretion in a glucose level-dependent manner, ultimately lowering blood glucose levels. Additionally, it decreases appetite and cravings for food, reduces the preference for energy-rich foods, and enhances control over eating habits.

 

It works by slowing down gastric emptying. When the stomach takes more time to empty itself of food, it sends signals of “fullness” to the brain. This process produces a powerful appetite suppression effect based on the patient’s natural insulin production. This means patients can benefit from medically assisted weight loss without any need for invasive surgeries or harsh stimulants. A Semaglutide regimen will also lead to healthier blood sugar levels, which can help patients feel more energetic throughout their day. Stabilized and controlled blood sugar levels can also help improve other areas of overall health. 

 

At JLoo Beauty Experts, we understand the significant impact that overweight and obesity can have on overall health. According to the Centers for Disease Control and Prevention (CDC), individuals with a BMI over 25 are considered overweight, while a BMI over 30 is classified as obesity. These conditions are associated with various health risks, making weight reduction a crucial aspect of wellness.

​

Lifestyle interventions and dietary modifications are often the initial steps in addressing weight concerns. However, for individuals who may benefit from additional support, the Food and Drug Administration (FDA) has approved several medications for long-term use in managing obesity. These include orlistat, phentermine-topiramate, naltrexone-bupropion, liraglutide, and semaglutide. Glucagon peptide-1 receptor agonists (GLP-1 RA) have been identified as the most promising intervention in treating obesity

​

Clinical Evidence on Efficacy of Semaglutide

Semaglutide, administered subcutaneously once a week, has emerged as a promising option for weight loss. Approved by the FDA in 2021, semaglutide 2.4 mg is indicated for adults with overweight (BMI >27 kg/m2) with at least one weight-associated condition or adults with a BMI of 30 kg/m2 or greater.

​

Experience the long-term efficacy and safety of semaglutide in supporting weight loss, as demonstrated by a recent systematic review and meta-analysis of randomized controlled trials conducted by the American Heart Association Journal. The study found that semaglutide led to significant weight loss in individuals with obesity or overweight but without diabetes, with an impressive 86.5% of participants achieving clinically meaningful weight loss of 5% or more of their body weight (95% CI 1.26, 4.64). Unlock the potential of semaglutide injections as part of our medical-guided treatment program to help you achieve your weight loss goals safely and effectively. 

Read article here: https://www.ahajournals.org/doi/10.1161/circ.148.suppl_1.15741#:~:text=A%20total%20of%2086.5%25%20of,%25%20CI%201.26%2C%204.64).

​

In line with recent research findings, JLoo Beauty Experts is excited to offer a weight loss program incorporating semaglutide as part of a comprehensive approach to wellness.

​

​

​

​

​

​

​

​